Thus, in order to relieve the chemo-resistant effect by IGF-1, IGF-1 receptor (IGF-1R) inhibitors combined with chemical drugs have been applied to treat PDA in clinical trials. The gene discussed is IGF1; the disease is Patent ductus arteriosus.